相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Priming of PRAME- and WT1-specific CD8+ T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy
Willemijn van den Ancker et al.
ONCOIMMUNOLOGY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Comparative Analysis of Various Tumor-Associated Antigen-Specific T-Cell Responses in Patients with Hepatocellular Carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2011)
Potential targets for pancreatic cancer immunotherapeutics
Lindzy F. Dodson et al.
IMMUNOTHERAPY (2011)
Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
Miho Kaida et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment
Puneet Singh et al.
PANCREAS (2011)
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination
Masanori Noguchi et al.
CANCER BIOLOGY & THERAPY (2010)
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
Motoki Miyazawa et al.
CANCER SCIENCE (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation
Dan Laheru et al.
CLINICAL CANCER RESEARCH (2008)
Toward the development of multi-epitope p53 cancer vaccines:: An in vitro assessment of CD8+ T cell responses to HLA class I-restricted wild-type sequence p53 peptides
Koichi Sakakura et al.
CLINICAL IMMUNOLOGY (2007)
Potential target antigens for immunotherapy in human pancreatic cancer
F. H. Schmitz-Winnenthal et al.
CANCER LETTERS (2007)
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
S. L. Bernhardt et al.
BRITISH JOURNAL OF CANCER (2006)
Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1
Hidenobu Ishizaki et al.
CLINICAL CANCER RESEARCH (2006)
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
G Bellone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2006)
In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire
WY Ho et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
S Wada et al.
CANCER RESEARCH (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients
XY Shang et al.
CLINICAL CANCER RESEARCH (2004)
Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8+ T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay
K Kuzushima et al.
BLOOD (2001)
Identification of p53 peptides recognized by CD8+ T lymphocytes from patients with bladder cancer
E Ferriès et al.
HUMAN IMMUNOLOGY (2001)
Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes
J Arai et al.
BLOOD (2001)
Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53
Y Umano et al.
BRITISH JOURNAL OF CANCER (2001)
Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2/neu: possible immunotherapy for colorectal carcinomas
H Tanaka et al.
BRITISH JOURNAL OF CANCER (2001)
Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
M Nakao et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
